Clinical Trial Update: Biomarkers of ADHD Treatment Response [Phase 1]

View source ↗

Summary

A Phase 1 trial at Boston Children's Hospital is investigating biomarkers that predict response to ADHD treatment, and the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Snippet

Sponsor: Boston Children's Hospital | Conditions: ADHD | Phase 1 | Status: COMPLETED